Estracyt and hepatic function abnormal Patient Reports February 13, 2012

Estracyt Side Effects Report #4751401-3
Estracyt side effect was reported by a Health Professional from JAPAN on Aug 08, 2005. Male patient, 87 years of age, was diagnosed with prostate cancer  and was treated with Estracyt. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, hepatic function abnormal, jaundice . Estracyt dosage: 280 MG, ORAL. During the same period patient was treated with SULPHATE, PRANLUKAST, TULOBUTEROL, SPIRONOLACTONE, METILDIGOXIN, KETOPROFEN, FUROSEMIDE, SENNOSIDE A. Patient was hospitalized. Patient recovered.

Estracyt Side Effects Report #4757747-7
Estracyt side effect was reported by a Physician from JAPAN on Aug 18, 2005. Male patient, 82 years of age, was diagnosed with prostate cancer  and was treated with Estracyt. After drug was administered, patient experienced the following side effects: diet refusal, hepatic function abnormal, liver abscess, metastatic neoplasm, poriomania, psychiatric symptom, soliloquy. Estracyt dosage: 626.8 MG, ORAL. During the same period patient was treated with TAMSULOSIN HYDROCHLORIDE, FLUTAMIDE. Patient was hospitalized. Patient recovered.

Estracyt Side Effects Report #5053457-X
Estracyt side effect was reported by a Consumer or non-health professional from JAPAN on June 19, 2006. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Estracyt. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Estracyt dosage: 626.8 MG, ORAL. During the same period patient was treated with LEUPROLIDE ACETATE, PREDNISOLONE. Patient recovered.